Resection of extrahepatic bile ducts with partial hepatectomy for treating intra- and extrahepatic hepatolithiasis. [PDF]
Xia H +6 more
europepmc +1 more source
Restoration of Bile Ducts in Drug-induced Vanishing Bile Duct Syndrome Due to Zonisamide.
Prolonged drug-induced cholestasis may be due to destruction and disappearance of bile ducts, sometimes referred to as vanishing bile duct syndrome. Although some of these cases progress to fibrosis, cirrhosis, and liver failure, others improve with time.
Vuppalanchi, Raj
core
ABSTRACT Background and Aims Peroral cholangioscopy‐guided lithotripsy (POCS‐L) has emerged as a treatment option for difficult bile duct stones (DBDSs), but detailed evidence remains limited. This study evaluated its effectiveness, safety, and risk factors for adverse events (AEs).
Hirohito Minami +9 more
wiley +1 more source
Trends in Mortality From Malignant Neoplasms of the Liver and Intrahepatic Bile Ducts in the United States: A Retrospective Analysis From 1999 to 2020. [PDF]
Talat F +7 more
europepmc +1 more source
Generation of multilineage liver organoids with luminal vasculature and bile ducts from human pluripotent stem cells via modulation of Notch signaling. [PDF]
Kim HJ +12 more
europepmc +1 more source
ABSTRACT Background Respiratory motion artifacts impair diagnostic accuracy in gadoxetic acid disodium (Gd‐EOB‐DTPA)‐enhanced liver MRI. Conventional verbal pre‐scan breathing training often yields inconsistent patient cooperation and image quality, creating an urgent clinical need for optimized training methods.
Li Mei +7 more
wiley +1 more source
Anatomical Variations of the Gallbladder and Bile Ducts: An MRI Study. [PDF]
Yason K +5 more
europepmc +1 more source
Feasibility of endoscopic papillary large balloon dilation to remove difficult stones in patients with nondilated distal bile ducts. [PDF]
Pereira Lima JC +7 more
europepmc +1 more source
Success of transition to adult care in patients with pediatric‐onset chronic liver disease
Abstract Objectives Previous studies on chronic pediatric‐onset conditions have highlighted the risks of loss to follow‐up, disease progression, or therapeutic nonadherence during transition. However, very few studies have focused on liver diseases.
Sarah Mongbo +8 more
wiley +1 more source

